Moderna to start testing vaccine which fights the South Africa strain

Renowned American biotech firm, Moderna, has reportedly announced that it is currently working with a number of government scientists in South Africa to study the efficacy of an experimental booster dose designed specifically to target the South African strain of the coronavirus.

The biote

Cartesian Therapeutics initiates Phase 2 Trial of multiple myeloma therapy

Driven by the need to develop an effective frontline cell therapy treatment for multiple myeloma, Cartesian Therapeutics, a clinical-stage biopharmaceutical company specializing in mRNA-engineered cell therapy, has announced the initiation of a Phase 2a clinical trial of Descartes-11, a new mRNA